GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023 · Nature · 190 citations
https://doi.org/10.1038/s41586-023-06034-3
A
Ana Fernández‐Cruz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
200
Papers
5.3K
Citations
36
h-index
103
i10-index
Ana Fernández‐Cruz is an academic researcher from Hospital Universitario Puerta de Hierro Majadahonda. The author has contributed to research in topics: Infective Endocarditis Diagnosis and Management & COVID-19 Clinical Research Studies & Antifungal resistance and susceptibility. The author has an h-index of 36, co-authored 170 publications.
ORCID: 0000-0003-1189-1120Papers by this author
worksThe NOVA Score: A Proposal to Reduce the Need for Transesophageal Echocardiography in Patients With Enterococcal Bacteremia
2014 · Clinical Infectious Diseases · 105 citations
https://doi.org/10.1093/cid/ciu872
The NOVA Score: A Proposal to Reduce the Need for Transesophageal Echocardiography in Patients With Enterococcal Bacteremia
2014 · Clinical Infectious Diseases · 105 citations
https://doi.org/10.1093/cid/ciu872
A Contemporary Picture of Enterococcal Endocarditis
2020 · Journal of the American College of Cardiology · 92 citations
https://doi.org/10.1016/j.jacc.2019.11.047
Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
2020 · Infectious Diseases and Therapy · 52 citations
https://doi.org/10.1007/s40121-020-00373-8
Bacterial infections in patients hospitalized with COVID-19
2021 · Internal and Emergency Medicine · 48 citations
https://doi.org/10.1007/s11739-021-02824-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat